Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Jul;31(7):1033-40.
doi: 10.1002/mds.26598. Epub 2016 Apr 8.

Phenotypic insights into ADCY5-associated disease

Affiliations

Phenotypic insights into ADCY5-associated disease

Florence C F Chang et al. Mov Disord. 2016 Jul.

Abstract

Background: Adenylyl cyclase 5 (ADCY5) mutations is associated with heterogenous syndromes: familial dyskinesia and facial myokymia; paroxysmal chorea and dystonia; autosomal-dominant chorea and dystonia; and benign hereditary chorea. We provide detailed clinical data on 7 patients from six new kindreds with mutations in the ADCY5 gene, in order to expand and define the phenotypic spectrum of ADCY5 mutations.

Methods: In 5 of the 7 patients, followed over a period of 9 to 32 years, ADCY5 was sequenced by Sanger sequencing. The other 2 unrelated patients participated in studies for undiagnosed pediatric hyperkinetic movement disorders and underwent whole-exome sequencing.

Results: Five patients had the previously reported p.R418W ADCY5 mutation; we also identified two novel mutations at p.R418G and p.R418Q. All patients presented with motor milestone delay, infantile-onset action-induced generalized choreoathetosis, dystonia, or myoclonus, with episodic exacerbations during drowsiness being a characteristic feature. Axial hypotonia, impaired upward saccades, and intellectual disability were variable features. The p.R418G and p.R418Q mutation patients had a milder phenotype. Six of seven patients had mild functional gain with clonazepam or clobazam. One patient had bilateral globus pallidal DBS at the age of 33 with marked reduction in dyskinesia, which resulted in mild functional improvement.

Conclusion: We further delineate the clinical features of ADCY5 gene mutations and illustrate its wide phenotypic expression. We describe mild improvement after treatment with clonazepam, clobazam, and bilateral pallidal DBS. ADCY5-associated dyskinesia may be under-recognized, and its diagnosis has important prognostic, genetic, and therapeutic implications. © 2016 The Authors. Movement Disorders published by Wiley Periodicals, Inc. on behalf of International Parkinson and Movement Disorder Society.

Keywords: adenylyl cyclase; cerebral palsy; chorea; dyskinesia; dystonia.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Kindred pedigrees. Arrowheads indicate probands of each pedigree; black symbols, affected; white symbols, unaffected members; slashed symbols, deceased individuals. In the genetically analyzed individuals, + denotes the presence of the ADCY5 mutation, – denotes the absence of ADCY5 mutation.

Comment in

References

    1. Fernandez M, Raskind W, Wolff J, et al. Familial dyskinesia and facial myokymia (FDFM): a novel movement disorder. Ann Neurol 2001;49:486‐492. - PubMed
    1. Chen YZ, Matsushita MM, Robertson P, et al. Autosomal dominant familial dyskinesia and facial myokymia: single exome sequencing identifies a mutation in adenylyl cyclase 5. Arch Neurol 2012;69:630‐635. - PMC - PubMed
    1. Chen YZ, Friedman JR, Chen DH, et al. Gain‐of‐function ADCY5 mutations in familial dyskinesia with facial myokymia. Ann Neurol 2014;75:542‐549. - PMC - PubMed
    1. Carapito R, Paul N, Untrau M, et al. A de novo ADCY5 mutation causes early‐onset autosomal dominant chorea and dystonia. Mov Disord 2015;30:423‐427. - PubMed
    1. Mencacci NE, Erro R, Wiethoff S, et al. ADCY5 mutations are another cause of benign hereditary chorea. Neurology 2015;85:80‐88. - PMC - PubMed

Publication types